# Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products Containing Coal Tar and Menthol for Over-the-Counter Human Use; Amendment to the Monograph
> **Food and Drug Administration** · Final rule. · Published 2007-03-06 · Effective 2007-04-05 · 72 FR 9849
## Document
- **Document number:** E7-3808
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 9849
- **CFR reference:** 21 CFR 310
- **Publication date:** 2007-03-06
- **Effective date:** 2007-04-05
- **HHS docket:** Docket No. 2005N-0448
## Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA did not receive any comments or data in response to its previously proposed rule to include this combination. This final rule is part of FDA's ongoing review of OTC drug products.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/03/06/E7-3808/dandruff-seborrheic-dermatitis-and-psoriasis-drug-products-containing-coal-tar-and-menthol-for)
---
*AI Analytics · CC0 1.0*